Project Grant R34DA066389
Award Date 8/15/26
Completion Date 7/31/29
Dollars Obligated $176K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
- The National Institute on Drug Abuse awarded New York University $771,043 on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a hybrid type II implementation-effectiveness trial of a peer change agent intervention designed to increase pre-exposure prophylaxis and medication for opioid use disorder uptake among people who inject drugs. The study, titled "A Social Network Approach to Improve HIV Prevention and Substance Use Treatment for People Who...
- The National Institute on Drug Abuse awarded Emory University $748,287 on April 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279), to estimate population size and health indicators for people who inject drugs across U.S. cities and to develop age-stratified population estimates. The project runs through January 31, 2031, with place of performance in Atlanta, Georgia. Injection drug use carries high risk for overdose, HIV, and hepatitis C infection; however, the most...
- The National Institute on Drug Abuse awarded Emory University $1.730699 million on September 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to implement and rigorously evaluate a peer recovery coach program in jails serving the Atlanta, Georgia area through May 31, 2030. The award funds implementation of a virtual peer recovery telehealth model adapted to three high-throughput jails in the Atlanta area. The program engages peer recovery coaches with lived experience...
- The National Institute on Drug Abuse awarded the University of South Carolina $721,308 on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research identifying current and emerging HIV/substance use disorder hotspots through predictive modeling. The research examines the prevalence and correlates of substance use disorder among people living with HIV, who experience rates 6.5 times higher than the general U.S. population, and analyzes the interplay...
- The National Institute on Drug Abuse awarded Massachusetts General Hospital $197,640 on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a four-year project examining the clinical impact and cost-effectiveness of integrating infectious disease care into rapid-access substance use bridge clinics. The research addresses the syndemic of substance use disorder and infections among people who inject drugs, who face elevated risk of overdose, acute bacterial...
- The National Institute on Drug Abuse awarded The Johns Hopkins University $155,500 under the Drug Use and Addiction Research Programs (CFDA 93.279) on August 1, 2026, to develop and pilot the PROTECT-ED intervention, which addresses overdose and HIV prevention for individuals recently released from incarceration. The award funds research to refine and test an emergency department–based intervention designed to identify recently incarcerated patients and offer same-day medications for opioid...
- The National Institute on Drug Abuse awarded the University of Miami $164,766 on August 19, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct implementation research on telehealth models for HIV and substance use disorder care among people who inject drugs. The research, guided by the Implementation Research Logic Model, will explore patterns of existing healthcare services at organizations serving people who inject drugs nationwide and identify implementation...
- The National Institute on Drug Abuse awarded Albert Einstein College of Medicine $756,000 on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct formative research on improving pre-exposure prophylaxis (PrEP) engagement among hospitalized people who use substances through addiction consult services. The project, executed through March 2029 in Bronx, New York, comprises three research aims. First, semi-structured interviews with twenty hospitalized people...
- The National Institute on Drug Abuse, part of the Department of Health and Human Services National Institutes of Health, awarded The Trustees of Columbia University in the City of New York $172,160 on December 9, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds a postdoctoral fellowship to examine how HIV-specific state legal policies function as barriers to perinatal care and drug use treatment engagement among pregnant women. The research employs a...
- The National Institute on Drug Abuse awarded the University of Miami $677,248 on February 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a randomized controlled trial testing the Comprehensive Tele-Health Concierge (C-THR) model, a peer-driven telehealth intervention designed to improve HIV pre-exposure prophylaxis (PrEP) initiation and retention among people with drug use histories exiting county jails. The award funds three primary research aims:...